VOLUME 14 ISSUE 3 2004

S Köse, K Sayar, İ Ak, N Aydın, Ü Kalelioğlu, İ Kırpınar, RA Reeves, TR Przybeck, CR Cloninger
Turkish version of the Temperament and Character Inventory (TCI): Reliability, validity, and factorial structure
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2004;14(3):107-131

 
 
M Şaylan, K Alptekin, A Akdemir, E Tetik, FA Korb
The intercontinental schizophrenia outpatient health outcomes (IC-SOHO) study: Baseline clinical and functional characteristics and antipsychotic use patterns in Turkey
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2004;14(3):132-142

 
 
S Ebrinç, ÜB Semiz, C Başoglu, M Çetin, AF Baykız, H Kandilcioğlu, H Balıbey
Efficacy and safety of amisulpride treatment in schizophrenia: Comparison with haloperidol
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2004;14(3):143-149

 
 
A Altındağ, M Yanık, M Nebioğlu
Neuroleptic malignant syndrome in two brothers with mental retardation
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2004;14(3):150-153

 
 
Ö Gencer, S Miral, T Güvenir
Long-term olanzapine use in two adolescent cases with bipolar disorder
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2004;14(3):154-158

 
 
H Kayır, İT Uzbay
Central adenosinergic system and its clinical importance
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2004;14(3):159-167

 
 
L Mete, PÇ Ünsal
Metabolic side effects of new generation antipsychotics
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2004;14(3):168-177

 
 
BB Akdede, K Alptekin
Cognitive impairment and antipsychotic treatment in schizophrenia
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2004;14(3):178-184